Summary of Purpose
Clinical randomized clinical trial to assess the effectiveness on walking speed of repeated use of botulinum neurotoxin type A (BoNT/A)in the post-stroke spastic equinovarus foot in three successive infiltrations at 6-month intervals, checking if the sustainability of the effect is greater in incobotulinumtoxin A (Xeomin®) than in onabotulinumtoxinA (Botox®).Read More →
The following dates are available for this trial. Trial information last updated on 3 February 2017.
|1 Jan 2015||1 Feb 2017||30 Jun 2017||30 Jun 2017||1 Feb 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Parc de Salut Mar Lead
- Esther Duarte, PhD
email@example.com +34 933674214